A study led by the National Cardiovascular Center in Japan investigated the potential benefits of dapagliflozin, a medication for type 2 diabetes, in patients with chronic heart failure and diabetes. ...
Copyright © 2013-24 MediaBites, Designed & Developed By Global Biz International.
Copyright © 2013-24 MediaBites, Designed & Developed By Global Biz International.